{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:48:11Z","timestamp":1761662891032},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1093\/jac\/dkq334","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T00:59:32Z","timestamp":1285117172000},"page":"2423-2427","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem"],"prefix":"10.1093","volume":"65","author":[{"given":"C\u00e9dric","family":"Bretonni\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Jacqueline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Le Mabecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Fran\u00e7oise","family":"Mi\u00e9geville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Villers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Potel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,9,21]]},"reference":[{"key":"key\n\t\t\t\t20170425173317_DKQ334C1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.qco.0000171920.44809.f0","article-title":"Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting","volume":"18","author":"Navon-Venezia","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20170425173317_DKQ334C3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2005.01161.x","article-title":"Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa","volume":"11","author":"Rossolini","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C4","volume-title":"Recommandations 2009","author":"Comit\u00e9 de l'antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","year":"2009"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dkf131","article-title":"Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones","volume":"50","author":"Croisier","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1469-0691.2006.01371.x","article-title":"In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin","volume":"12","author":"Martha","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C7","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.43.10.2484","article-title":"Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics","volume":"43","author":"Piroth","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijantimicag.2008.10.029","article-title":"In vivo impact of the MexAB-OprM efflux system on \u03b2-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection","volume":"33","author":"Boutoille","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/bulm.1997.0013","article-title":"In vivo simulation of human pharmacokinetics in the rabbit","volume":"60","author":"Bugnon","year":"1998","journal-title":"Bull Math Biol"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1179\/joc.2001.13.1.70","article-title":"Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia","volume":"13","author":"Alvarez Lerma","year":"2001","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jac\/dkh298","article-title":"Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations","volume":"54","author":"Jones","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/600036","article-title":"Doripenem","volume":"49","author":"Paterson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C14","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.48.8.3136-3140.2004","article-title":"Activities of doripenem (S-4661) against drug-resistant clinical pathogens","volume":"48","author":"Jones","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C15","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00424-08","article-title":"Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men","volume":"52","author":"Cirillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1358\/dot.2006.42.6.985634","article-title":"Doripenem","volume":"42","author":"Anderson","year":"2006","journal-title":"Drugs Today (Barc)"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jac\/dkq044","article-title":"Stability of meropenem and doripenem solutions for administration by continuous infusion","volume":"65","author":"Berthoin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.clinthera.2008.04.019","article-title":"Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study","volume":"30","author":"Lucasti","year":"2008","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jac\/dki375","article-title":"Pharmacokinetics of imipenem in healthy volunteers following administration by 2 h or 0.5 h infusion","volume":"56","author":"Jaruratanasirikul","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170425173317_DKQ334C21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/11\/2423\/13759450\/dkq334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:18:59Z","timestamp":1559693939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkq334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,21]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,9,21]]},"published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkq334","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,21]]}}}